Evidence map›Paper›PMID 18456875›Full record

ArticleBlood2008

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.

Dimitrios I Zonios, Judith Falloon, John E Bennett, Pamela A Shaw, Doreen Chaitt, Michael W Baseler, Joseph W Adelsberger, Julia A Metcalf, Michael A Polis, Stephen B Kovacs and 6 more

Erratum issuedOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 216 citations in OpenAlex.

  1. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  2. Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.The New England journal of medicine · 2023
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Severe disseminatedIDCases · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Kovacs, Stephen J [corrected to Kovacs, Stephen B]
5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Dimitrios I ZoniosLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Judith Falloon
John E Bennett
Pamela A Shaw
Doreen Chaitt
Michael W Baseler
Joseph W Adelsberger
Julia A Metcalf
Michael A Polis
Stephen B Kovacs
Stephen J Kovacs
Joseph A Kovacs
Richard T Davey
H Clifford Lane
Henry Masur
Irini Sereti
National Institutes of Health · USScience Applications International Corporation (United States) · US

Funding

Immunologic/Virologic Approaches To HIV-1 TherapeuticsZ01AI000865 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI DAVEY, RICHARD · 2000 to 2008
$4.6M
PATHOGENIC MECHANISMS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTIONSZ01AI000585 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI LANE, HENRY C · 1990 to 2008
$4.5M
Molecular Genetics, Biochemistry And Therapy Of Pathogenic FungiZIAAI000654 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BENNETT, JOHN E · 2009 to 2014
$3.4M
NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400
6 · The paper itself

Abstract

Idiopathic CD4(+) lymphocytopenia (ICL) is a rare non-HIV-related syndrome with unclear natural history and prognosis. This prospective natural history cohort study describes the clinical course, CD4 T lymphocyte kinetics, outcome, and prognostic factors of ICL. Thirty-nine patients (17 men, 22 women) 25 to 85 years old with ICL were evaluated between 1992 and 2006, and 36 were followed for a median of 49.5 months. Cryptococcal and nontuberculous mycobacterial infections were the major presenting opportunistic infections. Seven patients presented with no infection. In 32, CD4 T-cell counts remained less than 300/mm(3) throughout the study period and in 7 normalized after an average of 31 months. Overall, 15 (41.6%) developed an opportunistic infection in follow-up, 5 (13.8%) of which were "AIDS-defining clinical conditions," and 4 (11.1%) developed autoimmune diseases. Seven patients died, 4 from ICL-related opportunistic infections, within 42 months after diagnosis. Immunologic analyses revealed increased activation and turnover in CD4 but not CD8 T lymphocytes. CD8 T lymphocytopenia (< 180/mm(3)) and the degree of CD4 T cell activation (measured by HLA-DR expression) at presentation were associated with adverse outcome (opportunistic infection-related death; P = .003 and .02, respectively).

Indexed as

AdultAgedAged, 80 and overAutoimmune DiseasesFemaleFollow-Up StudiesHumansLymphocyte ActivationLymphopeniaMaleMiddle AgedOpportunistic InfectionsPrognosisProspective StudiesSurvival AnalysisT-Lymphocytes

Identifiers

PMID18456875
PMCPMC2442741
OpenAlexW2070849769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.